Crescent Capital BDC (CCAP) to Release Earnings on Monday

Crescent Capital BDC (NASDAQ:CCAP) is set to post its quarterly earnings results after the market closes on Monday, November 11th. Analysts expect Crescent Capital BDC to post earnings of $0.57 per share for the quarter. Individual that are interested in registering for the company’s earnings conference call can do so using this link.

Crescent Capital BDC (NASDAQ:CCAP) last released its earnings results on Monday, August 12th. The company reported $0.59 EPS for the quarter, beating analysts’ consensus estimates of $0.58 by $0.01. The company had revenue of $48.95 million during the quarter, compared to analysts’ expectations of $48.05 million. Crescent Capital BDC had a return on equity of 12.03% and a net margin of 51.61%. During the same quarter last year, the business posted $0.56 EPS. On average, analysts expect Crescent Capital BDC to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Crescent Capital BDC Price Performance

Shares of CCAP stock opened at $18.02 on Monday. The business’s fifty day moving average is $18.42 and its 200 day moving average is $18.36. The company has a quick ratio of 1.40, a current ratio of 1.40 and a debt-to-equity ratio of 1.17. The stock has a market cap of $667.82 million, a price-to-earnings ratio of 6.55 and a beta of 0.81. Crescent Capital BDC has a twelve month low of $15.91 and a twelve month high of $19.63.

Crescent Capital BDC Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, October 15th. Stockholders of record on Monday, September 30th were given a $0.42 dividend. The ex-dividend date was Monday, September 30th. This is an increase from Crescent Capital BDC’s previous quarterly dividend of $0.09. This represents a $1.68 dividend on an annualized basis and a dividend yield of 9.32%. Crescent Capital BDC’s dividend payout ratio is currently 61.09%.

Analysts Set New Price Targets

Several equities research analysts recently commented on CCAP shares. LADENBURG THALM/SH SH initiated coverage on shares of Crescent Capital BDC in a research note on Monday, September 30th. They set a “buy” rating and a $20.00 price objective on the stock. Bank of America reduced their price objective on shares of Crescent Capital BDC from $20.00 to $19.00 and set a “buy” rating for the company in a research note on Thursday, August 15th. Finally, Wells Fargo & Company dropped their target price on shares of Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating on the stock in a research note on Wednesday, August 14th. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $19.00.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.